AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939

PRESS RELEASE AB SCIENCE RELEASES INITIAL DATA ON THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE ...
Xinhuanet

China Focus: Chinese women forge key contributions to space exploration

BEIJING, Oct. 14 (Xinhua) -- A new generation of female talent, from astronauts to chief designers, is forging crucial contributions to China's space exploration endeavors, supported by national ...

CBSE Class 10 Deleted Syllabus 2025-26: Subject-wise List of Removed Topics for Board Exam 2026

Check subject-wise list of topics and chapters removed from Class 10 Maths, Science, Social Science, English and Hindi syllabus. Know which portions to skip for CBSE Board Exam 2026 based on the ...

🌱 Patch AM: Quiz Night at the Grape and 11 more events

Be sure to catch Locally Trained Artists Present The Headless Horseman + Viva La Vida, Oct 25-26 College of San Mateo on the ...

AlzeCure Pharma: Response Letter to Previous Article Published about Alzstatin's Unique Mode of Action Against Alzheimer's

STOCKHOLM, SE / ACCESS Newswire / October 14, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the n ...
Le Lézard

Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025

Gilead Sciences, Inc. and Kite, a Gilead Company, will demonstrate progress in our commitment to transform how cancer is treated with new data at the European Society for Medical Oncology (ESMO) 2025 ...